{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-023843","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.741675+00:00","generated_at":"2026-06-22T01:59:57.906412+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Alpha Teknova Q3 revenue up 14% to $10.7M, net loss widens on $16.6M goodwill impairment","bullets":["Revenue $10.7M (+14% YoY); Lab Essentials $9.47M (+32%).","Net loss $22.5M ($0.80 loss per share) vs loss $3.3M in Q3 2021; includes $16.6M non-cash goodwill impairment.","Adjusted EBITDA -$4.6M vs -$2.7M; Free Cash Flow -$14.9M.","FY2022 revenue guidance lowered to $40-42M (midpoint ~16% growth excl. Sample Transport).","Cash $49.9M; new facility qualification underway, research-grade production expected by end of 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-023843","json":"https://secwatch.observer/filing/0000950170-22-023843.json","markdown":"https://secwatch.observer/filing/0000950170-22-023843.md","text":"https://secwatch.observer/filing/0000950170-22-023843.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000095017022023843/0000950170-22-023843-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000095017022023843/tkno-20221109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T01:59:57.906412+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}